{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:12:22Z","timestamp":1771575142244,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Oral immunization with vaccines may be an effective strategy for prevention of <jats:italic>Clostridium difficile<\/jats:italic> infection (CDI). However, application of previously developed vaccines for preventing CDI has been limited due to various reasons. Here, we developed a recombinant <jats:italic>Lactococcus lactis<\/jats:italic> oral vaccine and evaluated its effect on a <jats:italic>C. difficile-<\/jats:italic>infected animal model established in golden hamsters in attempt to provide an alternative strategy for CDI prevention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Recombinant <jats:italic>L. lactis<\/jats:italic> vaccine was developed using the pTRKH2 plasmid, a high-copy-number <jats:italic>Escherichia coli<\/jats:italic>-<jats:italic>L.<\/jats:italic> shuttle vector: 1) <jats:italic>L. lactis<\/jats:italic> expressing secreted proteins was constructed with recombinant pTRKH2 (secreted-protein plasmid) carrying the Usp45 signal peptide (SPUsp45), nontoxic adjuvanted tetanus toxin fragment C (TETC), and 14 of the 38 C-terminal repeats (14CDTA) of nontoxic <jats:italic>C. difficile<\/jats:italic> toxin A (TcdA); and 2) <jats:italic>L. lactis<\/jats:italic> expressing secreted and membrane proteins was constructed with recombinant pTRKH2 (membrane-anchored plasmid) carrying SPUsp45, TETC, 14CDTA, and the cell wall-anchored sequence of protein M6 (cwaM6). Then, 32 male Syrian golden hamsters were randomly divided into 4 groups (n\u2009=\u20098 each) for gavage of normal saline (blank control) and <jats:italic>L. lactis<\/jats:italic> carrying the empty shuttle vector, secreted-protein plasmid, and membrane-anchored plasmid, respectively. After 1-week gavage of clindamycin, the animals were administered with <jats:italic>C. difficile<\/jats:italic> spore suspension. General symptoms and intestinal pathological changes of the animals were examined by naked eye and microscopy, respectively. Protein levels of anti-TcdA IgG\/IgA antibodies in intestinal tissue and fluid were analyzed by enzyme-linked immunosorbent assay (ELISA). A cell culture cytotoxicity neutralization assay was done by TcdA treatment with or without anti-TcdA serum pre-incubation or treatment. Apoptosis of intestinal epithelial cells was examined by flow cytometry (FL) assay. Expression of mucosal inflammatory cytokines in the animals was detected by polymer chain reaction (PCR) assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>After the <jats:italic>C. difficile<\/jats:italic> challenge, the animals of control group had severe diarrhea symptoms on day 1 and all died on day 4, indicating that the CDI animal model was established in hamster. Of the 3 immunization groups, secreted-protein and membrane-anchored plasmid groups had significantly lower mortalities, body weight decreases, and pathological scores, with higher survival rate\/time than the empty plasmid group (P\u2009&lt;\u20090.05). The tilter of IgG antibody directed against TcdA was significantly higher in serum and intestinal fluid of secreted-protein and membrane-anchored plasmid groups than in the empty plasmid group (P\u2009&lt;\u20090.05) while the corresponding titer of IgA antibody directed against TcdA had no substantial differences (P\u2009&gt;\u20090.05). The anti-TcdA serum of membrane-anchored plasmid group neutralized the cytotoxicity of 200 ng\/ml TcdA with the best protective effect achieved by anti-TcdA serum pre-incubation. The incidences of TcdA-induced death and apoptosis of intestinal epithelial cells were significantly reduced by cell pre-incubation or treatment with anti-TcdA serum of membrane-anchored plasmid group (P\u2009&lt;\u20090.05). MCP-1, ICAM-1, IL-6, and Gro-1 mRNA expression levels were the lowest in cecum tissue of the membrane-anchored groups compared to the other groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Recombinant <jats:italic>L. lactis<\/jats:italic> live vaccine is effective for preventing CDI in the hamster model, thus providing an alternative for immunization of <jats:italic>C. difficile-<\/jats:italic>associated diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-13-117","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T16:18:32Z","timestamp":1374077912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model"],"prefix":"10.1186","volume":"13","author":[{"given":"Xiao-qiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,17]]},"reference":[{"issue":"68","key":"999_CR1","first-page":"75","volume":"13","author":"DN Gerding","year":"2012","unstructured":"Gerding DN: Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines. Discov Med. 2012, 13 (68): 75-83.","journal-title":"Discov Med"},{"issue":"4","key":"999_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ijantimicag.2008.09.022","volume":"33","author":"H Huang","year":"2009","unstructured":"Huang H, Wu S, Wang M, et al: Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Int J Antimicrob Agents. 2009, 33 (4): 339-342. 10.1016\/j.ijantimicag.2008.09.022.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"999_CR3","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1128\/IAI.66.5.2018-2025.1998","volume":"66","author":"JA Kink","year":"1998","unstructured":"Kink JA, Williams JA: Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect Immun. 1998, 66 (5): 2018-2025.","journal-title":"Infect Immun"},{"issue":"12","key":"999_CR4","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/iai.63.12.4619-4627.1995","volume":"63","author":"JF Torres","year":"1995","unstructured":"Torres JF, Lyerly DM, Hill JE, Monath TP: Evaluation of formalin-inactivated clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun. 1995, 63 (12): 4619-4627.","journal-title":"Infect Immun"},{"issue":"7","key":"999_CR5","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/iai.65.7.2941-2949.1997","volume":"65","author":"ET Ryan","year":"1997","unstructured":"Ryan ET, Butterton JR, Smith RN, Carroll PA, Crean TI, Calderwood SB: Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect Immun. 1997, 65 (7): 2941-2949.","journal-title":"Infect Immun"},{"issue":"5","key":"999_CR6","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/IAI.67.5.2145-2152.1999","volume":"67","author":"SJ Ward","year":"1999","unstructured":"Ward SJ, Douce G, Figueiredo D, Dougan G, Wren BW: Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect Immun. 1999, 67 (5): 2145-2152.","journal-title":"Infect Immun"},{"issue":"2","key":"999_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00253-004-1869-y","volume":"68","author":"H Pei","year":"2005","unstructured":"Pei H, Liu J, Cheng Y, Sun C, Wang C, Lu Y, Ding J, Zhou J, Xiang H: Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination. Appl Microbiol Biotechnol. 2005, 68 (2): 220-227. 10.1007\/s00253-004-1869-y.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"14","key":"999_CR8","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1128\/JB.183.14.4157-4166.2001","volume":"183","author":"Y Dieye","year":"2001","unstructured":"Dieye Y, Usai S, Clier F, Gruss A, Piard JC: Design of a protein-targeting system for lactic acid bacteria. J Bacteriol. 2001, 183 (14): 4157-4166. 10.1128\/JB.183.14.4157-4166.2001.","journal-title":"J Bacteriol"},{"issue":"2","key":"999_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1128\/AEM.68.2.910-916.2002","volume":"68","author":"LA Ribeiro","year":"2002","unstructured":"Ribeiro LA, Azevedo V, Le Loir Y, Oliveira SC, Dieye Y, Piard JC, Gruss A, Langella P: Production and targeting of the Brucella abortus antigen L7\/L12 in Lactococcus lactis: a first step towards food-grad live vaccines against Brucellosis. Appl Environ Microbiol. 2002, 68 (2): 910-916. 10.1128\/AEM.68.2.910-916.2002.","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"999_CR10","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1128\/IAI.72.6.3444-3450.2004","volume":"72","author":"P Mannam","year":"2004","unstructured":"Mannam P, Jones KF, Geller BL: Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun. 2004, 72 (6): 3444-3450. 10.1128\/IAI.72.6.3444-3450.2004.","journal-title":"Infect Immun"},{"issue":"1","key":"999_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0378-1119(93)90011-Q","volume":"137","author":"D O\u2019Sullivan","year":"1993","unstructured":"O\u2019Sullivan D, Klaenhammer TR: High and low copy number lactococcus shuttle coloning vectors with features for clone screening. Gene. 1993, 137 (1): 227-231.","journal-title":"Gene"},{"issue":"10","key":"999_CR12","first-page":"1232","volume":"25","author":"X Yang","year":"2005","unstructured":"Yang X, Peng C, Jiang P, Xing R, Zhang S, Chen X: Construction and identification of exogenous gene expression system in Lactococcus lactis. Chin J First Military Med Uni. 2005, 25 (10): 1232-1235.","journal-title":"Chin J First Military Med Uni"},{"issue":"18","key":"999_CR13","first-page":"1676","volume":"30","author":"X Yang","year":"2009","unstructured":"Yang X, Zhao Y, Sun D, Jiang P, Chen X: Expression of Clostridium difficile toxin A receptor binding domain in Lactococcus lactis. Chin J First Military Med Uni. 2009, 30 (18): 1676-1680.","journal-title":"Chin J First Military Med Uni"},{"issue":"7","key":"999_CR14","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1128\/JB.01765-07","volume":"190","author":"AS Joseph","year":"2008","unstructured":"Joseph AS, Abraham LS: Bile salts and glycine as co-germinants for Clostridium difficile spores. J Bacteriol. 2008, 190 (7): 2505-2512. 10.1128\/JB.01765-07.","journal-title":"J Bacteriol"},{"key":"999_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1074\/jbc.M611432200","volume":"282","author":"M Akoachere","year":"2007","unstructured":"Akoachere M, Squires RC, Nour AM, Angelov L, Brojatsch J, Abel-Santos E: Identification of an in vivo inhibitor of Bacillus anthracis spore germination. J Biol Chem. 2007, 282: 122-128.","journal-title":"J Biol Chem"},{"issue":"1","key":"999_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1309\/AJCPO3QWOU8CYGEU","volume":"133","author":"ME Reller","year":"2010","unstructured":"Reller ME, Alcabasa RC, Lema CA, Carroll KC: Comparison of two rapid assays for Clostridium difficile common antigen and a C. difficile toxin A\/B assay with the cell culture neutralization assay. Am J Clin Pathol. 2010, 133 (1): 107-109. 10.1309\/AJCPO3QWOU8CYGEU.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"999_CR17","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1128\/AAC.34.7.1348","volume":"34","author":"HE Larson","year":"1990","unstructured":"Larson HE, Borriello SP: Quantitative study of antibiotic-induced susceptibility to clostridium difficile enterocecitis in hamsters. Antimicrob Agents Chemother. 1990, 34 (7): 1348-1353. 10.1128\/AAC.34.7.1348.","journal-title":"Antimicrob Agents Chemother"},{"key":"999_CR18","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/iai.64.12.5225-5232.1996","volume":"64","author":"I Castagliuolo","year":"1996","unstructured":"Castagliuolo I, LaMont JT, Nikulasson ST, Pothoulakis C: Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun. 1996, 64: 5225-5232.","journal-title":"Infect Immun"},{"issue":"2","key":"999_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1503\/cmaj.050350","volume":"173","author":"N Dendukuri","year":"2005","unstructured":"Dendukuri N, Costa V, McGregor M, Brophy JM: Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ. 2005, 173 (2): 167-170.","journal-title":"CMAJ"},{"issue":"1","key":"999_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-2478(96)02678-8","volume":"55","author":"JP Vaerman","year":"1997","unstructured":"Vaerman JP, Langendries A: Hepatobiliary transport of IgA in the golden Syrian hamster (Mesocricetus auratus). Immunol Lett. 1997, 55 (1): 19-26. 10.1016\/S0165-2478(96)02678-8.","journal-title":"Immunol Lett"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-13-117\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:30:56Z","timestamp":1630546256000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-13-117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,17]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-13-117","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,17]]},"assertion":[{"value":"10 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"117"}}